Search

Your search keyword '"Ischemia-modified albumin"' showing total 1,003 results

Search Constraints

Start Over You searched for: Descriptor "Ischemia-modified albumin" Remove constraint Descriptor: "Ischemia-modified albumin"
1,003 results on '"Ischemia-modified albumin"'

Search Results

51. Kinetics of d-lactate and ischemia-modified albumin after abdominal aortic surgery and their ability to predict intestinal ischemia.

53. Can ischemia modified albumin level be regarded as an indicative marker of ulcerative colitis and its activity?

54. The clinical value of IMA and SCUBE1 in the diagnosis of acute appendicitis in children

55. The Role of Ischemia-modified Albumin and Ischemia-modified Albumin to Albumin Ratios in Patients with Alopecia Areata

56. Traditional and novel diagnostic biomarkers for acute myocardial infarction.

57. Hypoxia-inducible factor-1α and ischemia-modified albumin levels in intensive care COVID-19 Patients.

58. Importance of oxidative stress in the evaluation of acute pulmonary embolism severity.

59. Evaluation of thiol/disulfide hemostasis and serum Ischemia modified albumin as oxidative stress biomarkers in systemic lupus erythematosus patients: Relationship with major organ involvement and disease activity.

60. Thiol-Disulfide Homeostasis in Neonatal Patients with Urinary Tract Infection.

61. The study of association of serum ischemia-modified albumin and prediabetes in women: A case–control study.

62. A marker for acute cholecystitis severity: thiol-disulfide balance and ischemia-modified albumin.

63. Value of thiol and ischemia modified albumin (IMA) in predicting mortality in serious COVID-19 pneumonia

64. Evaluation of dynamic thiol/disulphide homeostasis and ischemia-modified albumin levels in sudden sensorineural hearing loss.

65. Serum ischemia modified albumin level in acute migraine attacks

66. Evaluation of Fetal Serum Thiol/Disulfide Homeostasis and Ischemia-Modified Albumin Levels in Fetal Distress.

67. Relationship of Thyroid Functions with ADMA, IMA, and Metabolic Laboratory Parameters in Euthyroid Adults with and without Autoimmune Thyroiditis.

68. Evaluation of cardiovascular risk in children with solitary functioning kidney.

69. Ischemia-Modified Albumin—A Potential New Marker of Oxidative Stress in Dermatological Diseases.

70. Diagnostic Accuracy of Ischemia-Modified Albumin for Acute Coronary Syndrome: A Systematic Review and Meta-Analysis.

71. CAN ISCHEMIA MODIFIED ALBUMIN LEVEL BE REGARDED AS AN INDICATIVE MARKER OF ULCERATIVE COLITIS AND ITS ACTIVITY?

72. Ischemia-Modified Albumin Levels in Patients with Bell's palsy.

73. The predictive value of ischemia-modified albumin in the diagnosis of acute appendicitis: A prospective case-control study.

74. Dynamic thiol/disulphide homeostasis in acute urticaria

76. An evaluation of maternal serum dynamic thioldisulfide homeostasis and ischemia modified albumin changes in pregnant women with COVID-19.

77. The Relationship between Serum Ischemia-Modified Albumin Levels and Uterine Artery Doppler Parameters in Patients with Primary Dysmenorrhea

78. An investigation of the effects on follicular-embryonal development and pregnancy outcomes of serum and follicular fluid ischemia-modified albumin in cases of unexplained infertility receiving in vitro fertilization treatment

79. Biomarkers of acute myocardial infarction: diagnostic and prognostic value. Part 1

80. Usefulness of ischemia-modified albumin in the diagnosis of sepsis/septic shock in the emergency department

81. The Significance of Thiol/Disulfide Homeostasis and Ischemia-modified Albumin Levels in Assessing Oxidative Stress in Obese Children and Adolescents

82. The role of thiol–disulfide and ischemia-modified albumin in the differential diagnosis of ovarian pathologies in children

83. A systematic review and meta-analysis of ischemia-modified albumin in diabetes mellitus.

84. Evaluation of the follicular fluid thiol/disulfide balance among patients with poor ovarian response.

85. Oxidative stress biomarkers in fetal growth restriction with and without preeclampsia.

86. Evaluation of dynamic/thiol disulphide balance and ischaemia modified albumin in children with trauma.

87. Dynamic thiol/disulphide homeostasis in acute urticaria.

88. Serum ischemia modified albumin level in acute migraine attacks.

89. An evaluation of ischaemia-modified albumin levels in the development of diabetic foot ulcer.

90. Serum Ischemia-Modified Albumin Levels, Myeloperoxidase Activity and Peripheral Blood Mononuclear cells in Autism Spectrum Disorder (ASD).

91. Effect of alveolar recruitment maneuver on ischemia-modified albumin and oxidative stress in laparoscopic cholecystectomy

92. Ischemia-modified albumin: a unique marker of global metabolic risk in schizophrenia and mood disorders

93. Relation of ischemia-modified albumin to disease manifestations and activity in Egyptian patients with Behҫet’s disease

94. Assessment of metabolic profile and ischemia-modified albumin level in patients with alopecia areata: A case–control study

95. Ischemia-modified albumin as a novel marker for diagnosis of necrotizing enterocolitis in newborn infants

96. 川崎病患儿血清趋化素和缺血修饰清蛋白水平与 冠状动脉损伤的相关性及在治疗中的应用价值.

97. Oxidative–Antioxidative Markers in Pregnant Women with Fetal Neural Tube Defects.

98. Ischemia-Modified Albumin—A Potential New Marker of Oxidative Stress in Dermatological Diseases

99. Diagnostic Accuracy of Ischemia-Modified Albumin for Acute Coronary Syndrome: A Systematic Review and Meta-Analysis

100. OXIDATIVE IMBALANCE IN AUTOIMMUNE LIVER DISEASE: EVALUATION OF OXIDANT-ANTIOXIDANT STATUS AND ISCHEMIA-MODIFIED ALBUMIN.

Catalog

Books, media, physical & digital resources